Impact of neuroendocrine neoplasm-specific systemic treatments on expression and function of CXCR4 in neuroendocrine tumor cells

Abstract As neuroendocrine neoplasms (NEN) undergo increasing dedifferentiation, CXC chemokine receptor type 4 (CXCR4) becomes upregulated. Higher levels of CXCR4 are associated with invasive growth, metastasis formation, and poor prognosis. CXCR4 is considered a potential diagnostic biomarker and a...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Christof Däubler, Clara Böttcher, Laura-Sophie Landwehr, Alexander Meining, K. Michalski, F. Reiter, Rudolf A. Werner, Philipp Hartrampf, Dorothee Rogoll, Alexander Weich
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2026-01-01
Reeks:	Scientific Reports
Onderwerpen:	Neuroendocrine neoplasm CXCR4 Cisplatin Everolimus Temozolomide Systemic therapy
Online toegang:	https://doi.org/10.1038/s41598-026-37026-8
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!